Clinical Trials List
Protocol Number580299/008
2004-07-01 - 2009-12-31
Phase III
Terminated3
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- CHI-HAU CHEN CHI-HAU CHEN Division of Obstetrics & Gynecology
- 陳瑞堅 Division of Obstetrics & Gynecology
- 施景中 Division of Obstetrics & Gynecology
- MEI-JOU CHEN Division of Obstetrics & Gynecology
- 黃思誠 Division of Obstetrics & Gynecology
- 徐明洸 Division of Obstetrics & Gynecology
- 張文君 Division of Obstetrics & Gynecology
- 張廷禎 Division of Obstetrics & Gynecology
- 童寶玲 Division of Obstetrics & Gynecology
- 林鶴雄 Division of Obstetrics & Gynecology
- 楊政憲 Division of Obstetrics & Gynecology
- BOR-CHING SHEU Division of Obstetrics & Gynecology
- 華筱玲 Division of Obstetrics & Gynecology
- 何弘能 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 張正昌 Division of Obstetrics & Gynecology
- Hung-Cheng Lai Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1700 participants
-
Global
18000 participants
